With determined leadership and smart use of current and future innovations, we can sustain momentum and accelerate progress ...

A team of scientists has identified an enzyme called PurF as a new drug target for tuberculosis, offering a fresh line of ...

There were an estimated 490,000 new cases of drug-resistant TB in 2016. Tuberculosis, a lung disease most often transmitted by breathing infected particles in the air, is the ninth leading cause of ...

Researchers from Imperial and the London School of Hygiene & Tropical Medicine (LSHTM) have discovered a drug target that ...

Despite newer TB drugs, delayed diagnosis, atypical symptoms and drug resistance continue to complicate treatment ...

Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking first-line regimens, ...

Tufts University researchers’ approach uncovers how TB treatments can best work together at the cellular level to speed better cures Tuberculosis (TB) is the world’s deadliest infectious disease—and ...

HONG KONG (Reuters) - Levels of drug-resistant tuberculosis (TB) in China are nearly twice the global average and almost 10 percent of cases are resistant to the most effective first-line drugs, a ...

Gordon was a reporter for TIME, based in the London bureau. The United Nations General Assembly's high-level meeting on the fight against tuberculosis TB is held at the UN headquarters in New York, on ...

For 2007, the WHO estimated 511,000 cases of multidrug-resistant (MDR)-TB, representing approximately 5% of all TB cases worldwide. Extensively drug-resistant (XDR-TB) strains have been detected in at ...